URL copied to clipboard
Alkem Laboratories Ltd.Fundamental Analysis English

1 min read

Alkem Laboratories Fundamental Analysis

Alkem Laboratories Ltd’s fundamental analysis highlights key financial metrics including market capitalization of ₹63,539.23 crore, PE ratio of 35.38, debt-to-equity ratio of 13.24, and return on equity of 17.82%. These figures reflect the company’s financial health and current market valuation.

Alkem Laboratories Ltd Overview

Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. It operates in the pharmaceutical sector, offering a wide range of products across various therapeutic areas.

The company has a market capitalization of ₹63,539.23 crore and is listed on both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). Currently, the stock is trading 4.98% below its 52-week high and 54.17% above its 52-week low.

Alice Blue Image

Alkem Laboratories Ltd Financial Results

Alkem Laboratories Ltd reported strong financials in FY 24 with a sales increase to ₹12,668 crore from ₹11,599 crore in FY 23. The company’s equity capital remained stable at ₹23.91 crore, while reserves grew to ₹10,288 crore. Net profit rose to ₹1,811 crore with an EPS of ₹150.19.

1. Revenue Trend: Sales increased from ₹11,599 crore in FY 23 to ₹12,668 crore in FY 24.

2. Equity and Liabilities: Total liabilities grew from ₹13,757 crore in FY 23 to ₹15,575 crore in FY 24, with current liabilities at ₹3,995 crore.

3. Profitability: Operating profit improved from ₹1,609 crore in FY 23 to ₹2,245 crore in FY 24, with an OPM of 18%.

4. Earnings per Share (EPS): EPS significantly increased from ₹82.31 in FY 23 to ₹150.19 in FY 24.

5. Return on Net Worth (RoNW): RoNW improved due to increased reserves and higher net profit.

6. Financial Position: Total assets grew from ₹13,757 crore in FY 23 to ₹15,575 crore in FY 24, with a rise in current assets from ₹8,730 crore to ₹10,412 crore.

Alkem Laboratories Ltd Financial Analysis

FY 24FY 23FY 22
Sales 12,66811,59910,634
Expenses 10,4229,9908,581
Operating Profit 2,2451,6092,053
OPM % 181419
Other Income 189113148
EBITDA 2,5561,8262,216
Interest 11210752
Depreciation 299310304
Profit Before Tax 2,0231,3051,844
Tax %10239
Net Profit1,8111,0071,680
EPS150.1982.31137.63
Dividend Payout %23.360.7524.7

* Consolidated Figures in Rs. Crores

Alkem Laboratories Limited Company Metrics

Alkem Laboratories’ market cap is ₹63,539.23 crore with a book value of ₹862 per share. The face value per share is ₹2. Total debt is ₹1,418.41 crore, ROE is 17.82%, and quarterly EBITDA is ₹477.63 crore. The dividend yield stands at 0.75%.

Market Capitalization: 

Market Capitalization represents the total market value of Alkem Laboratories’ outstanding shares, amounting to ₹63,539.23 crore.

Book Value: 

The book value per share of Alkem Laboratories is ₹862 indicating the value of the company’s net assets divided by its shares outstanding.

Face Value: 

The face value of Alkem Laboratories’ shares is ₹2, which is the nominal value of each share as stated on the share certificate.

Asset Turnover Ratio: 

The Asset Turnover Ratio of 0.88 measures how efficiently Alkem Laboratories uses its assets to generate sales revenue or sales income.

Total Debt: 

The Total Debt of Alkem Laboratories stands at ₹1,418.41 crore, representing the total amount of money the company owes to creditors.

Return on Equity (ROE): 

The ROE of 17.82% measures Alkem Laboratories’ profitability by revealing how much profit the company generates with the money shareholders have invested.

EBITDA (Q): 

The quarterly EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Alkem Laboratories is ₹477.63 crore, indicating the company’s operating performance.

Dividend Yield: 

The dividend yield of 0.75% shows the annual dividend payment as a percentage of Alkem Laboratories’ current share price, indicating the return on investment from dividends alone.

Alkem Laboratories Stock Performance

Alkem Laboratories Ltd has achieved a 1-year return on investment of 50.6%, a 3-year return of 16.0%, and a 5-year return of 26.5%. These returns illustrate the company’s consistent performance and growth potential for long-term investors.

PeriodReturn on Investment (%)
1 Year50.6 
3 Years16.0 
5 Years26.5 

Example: If an investor had invested ₹1,000 in the stock:

1 year ago, their investment would be worth ₹1,506.

3 years ago, their investment would have grown to approximately ₹1,160.

5 years ago, their investment would have increased to approximately ₹1,265.

Alkem Laboratories Peer Comparison

Alkem Laboratories Ltd has a current market price (CMP) of ₹5,715 and a market capitalization of ₹68,330 crore. With a P/E ratio of 35.38, ROE of 20%, and EPS of ₹172, it has shown a 1-year return of 51% and a dividend yield of 0.71%.Alkem Laboratories Ltd stands out with a CMP of ₹5,715, a market cap of ₹68,330 Cr, and a P/E ratio of 35. It has an ROE of 20%, an EPS of ₹172, and a 1-year return of 51%, showcasing solid profitability compared to its peers.

NameCMP Rs.Mar Cap Rs.Cr.P/EROE %EPS 12M Rs.1Yr return %ROCE %Div Yld %
Sun Pharma.Inds.1,7394,17,3284017435317        0.79
Cipla1,5961,28,8772917532823        0.82
Zydus Lifesci.1,2341,24,1693021429522.34        0.25
Dr Reddy’s Labs6,9061,15,218212133418.2626.53        0.58
Lupin2,12196,7234314509416        0.39
Aurobindo Pharma1,50588,1842512606814.1        0.31
Mankind Pharma2,13085,3174620481824.57            –  
Alkem Lab5,71568,33035201725120        0.71

Alkem Laboratories Shareholding Pattern

Alkem Laboratories Ltd has a promoter holding of 56.38% in June 2024, down from 56.74% in March 2024, and 57% in December 2023. FIIs hold 8.69%, DIIs hold 18.56%, and retail & others hold 16.37%, showing slight variations across the periods.

All values in %Jun-24Mar-24Dec-23
Promoters56.3856.7457
FII8.699.118.49
DII18.5615.6315.91
Retail & others16.3718.5118.86

Alkem Laboratories Limited History

Alkem Laboratories Limited is a prominent Indian pharmaceutical company with global operations. The company specializes in the development, manufacture, and sale of pharmaceutical and nutraceutical products. Alkem’s product portfolio covers a wide range of therapeutic areas, addressing various medical needs.

The company offers products across multiple therapeutic segments, including Anti-Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, and Central Nervous System (CNS) treatments. This diverse range allows Alkem to cater to a broad spectrum of medical conditions and patient needs.

Alkem Laboratories has established a significant presence both in India and internationally. With 21 manufacturing facilities across India and the United States, the company has a robust production capability. Alkem’s global reach extends to 40 countries, offering approximately 800 brands, demonstrating its strong market position and product diversity.

How To Invest In Alkem Laboratories Ltd Share?

To invest in Alkem Laboratories Ltd shares, begin by opening a demat account with Alice Blue. Complete the necessary KYC process and fund your account with the desired investment amount.

Research the company’s fundamentals, financial performance, and market trends before making an investment decision. Use the trading platform provided by the broker to place a buy order for Alkem Laboratories shares at your preferred price.

Monitor your investment regularly and stay informed about company news and market developments. Consider setting up a systematic investment plan (SIP) for long-term investing in the stock if it aligns with your financial goals.

Alice Blue Image

Alkem Laboratories Limited Fundamental Analysis – FAQs

1. What Is The Fundamental Analysis Of Alkem Laboratories Ltd?

Fundamental analysis of Alkem Laboratories Ltd examines key financial metrics: Market Cap (₹63,539.23 crore), PE Ratio (35.38), Debt to Equity (13.24), and Return on Equity (17.82%). These indicators provide insights into the company’s financial health, market valuation, and overall performance in the pharmaceutical sector.

2. What is the Market Cap of Alkem Laboratories?

The market capitalization of Alkem Laboratories is ₹63,539.23 crore. This figure represents the total value of the company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares outstanding.

3. What Is Alkem Laboratories Limited?

Alkem Laboratories Limited is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. It offers a wide range of medicines across various therapeutic areas and operates globally with a strong presence in India and international markets.

4. Who Is The Owner Of Alkem Laboratories?

Alkem Laboratories is a public limited company, with the Samprada Singh family as the promoters. While the promoter group holds a significant stake, it is a listed company with multiple shareholders including institutional investors and public shareholders.

5. Who Are The Main Shareholders Of Alkem Laboratories Ltd?

The main shareholders of Alkem Laboratories Ltd typically include the Samprada Singh family (promoter group) as major stakeholders, along with institutional investors (both domestic and foreign), mutual funds, and public shareholders. For the most current shareholding information, refer to the latest pattern disclosed by the company.

6. What Type Of Industry Is Alkem Laboratories?

Alkem Laboratories operates in the pharmaceutical industry. It specializes in the research, development, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company is a key player in the Indian pharmaceutical sector with a growing global presence.

7. How To Invest In Alkem Laboratories Ltd Share?

To invest in Alkem Laboratories shares, open a demat account with Alice Blue. Complete the KYC process and fund your account. Research the company thoroughly, then use the trading platform to place a buy order for the desired number of shares at your preferred price.

8. Is Alkem Laboratories Overvalued Or Undervalued?

Determining if Alkem Laboratories is overvalued or undervalued requires a comprehensive analysis of its financials, growth prospects, industry trends, and market conditions. Investors should consider metrics like the P/E ratio, and PEG ratio, and compare them with industry peers and historical values for a balanced assessment.

We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.

Shares Below 50BSE smallcapSmall Cap Logistics StocksStichting Depositary Apg Emerging Markets Equity Pool’s PortfolioTop Performed Value Fund in 10 years
Shares Below 1BSE TechSmall Cap Paper StocksFundamentally Strong Mid Cap StocksTop Performed Aggressive Hybrid Fund in 10 years
Hospitals stocks below 500Low pe ratio blue chip stocksSmall Cap IT Services StocksFundamentally Strong Stocks in NSEVedanta Ltd. Fundamental Analysis
Pipe Stock Below 500High-beta StocksSmall Cap Iron & Steel StocksFundamentally Strong Stocks in BSEWipro Ltd. Fundamental Analysis
Plastic Stocks Below 500Monopoly StocksMid Cap StocksFundamentally Strong Stocks Under 1 rsZomato Ltd. Fundamental Analysis
Best Commodity Chemicals Penny StocksLower Circuit StocksList Of Mid Cap Stocks In NseFundamentally Strong Stocks Under 20High Dividend Yield Packaging Stocks under Rs.500
Best Fertilizers Penny StocksUpper Circuit StocksBest Mid Cap Stocks Under 100 RsBest Performing Stocks in Last 5 YearsHigh Dividend Yield Pharma Stocks under Rs.500
Best Packaged Foods Penny StocksDebt Free Stocks Under 200 RsMidcap Stocks under 50Best Performing Stocks Last 1 MonthHighest Dividend Paying Stocks Under Rs.100
Best IT Hardware Penny StocksDebt Free
Companies
Midcap Stocks under 500Best Performing Stocks in Last 10 YearsHighest Dividend Paying Stocks Under Rs.1000
Best Telecomm Penny StocksBest Debt Free Stocks under Rs 1000Large Cap StocksBest Performing Stocks in Last 6 MonthsWhat Is Mutual Fund In Simple Words
List of Online Services StocksDebt Free Stocks Under 5Large Cap Stocks List In NseBest Performing Stocks in Last 1 YearsAdvantages and Disadvantages of Mutual Funds
Best Wood Product StocksDebt Free Stocks Under 20Large cap stocks under 100Top Logistic Stocks with High FII HoldingPartly Convertible Debentures
Long Term Logistics StocksLong Term Cables StocksLarge cap stocks under 200Food Stocks with High FII HoldingAlternative Investment Funds Vs Mutual Funds
Long Term Personal Products StocksLong Term Electrical Equipments StocksLarge cap stocks under 500Top Plastic Products Stocks with High FII HoldingLimit Order
Long Term Gas Distribution StocksLong Term Foods StocksList Of Kalyani StocksTop Rail Stocks with High FII HoldingCNC Order
Nifty Oil and GasLong Term Iron & Steel StocksList of Kirloskar StocksPackaged Food Stocks with High FII HoldingBTST Trading
Nifty CommoditiesLong Term Paper StocksMahindra & Mahindra Group StocksTire & Rubber Stocks with High DII HoldingWhat is Intraday Trading
Nifty HousingBest SIP Plans for 1000 Per MonthPiramal Ajay Group StocksFertilizer Stocks with High DII HoldingHow to Become a Sub Broker?
Nifty MidSmall IT & TelecomBest Performing Mutual Funds in Last 5 yearsMurugappa Group StocksPersonal Product Stocks with High DII HoldingSub Broker Terminal
Nifty India DigitalTop 10 Low Risk Mutual Funds for SIPIDBI Bank Limited PortfolioHospital Stocks with High ROCESensex vs Nifty
BSE PSUTop Mutual Funds for SIP 10 yearsAzim Premji PortfolioHotel Stocks with High ROCEWhat is Nifty?
BSE Cap GoodsBest Multi Cap Mutual FundsRamesh Damani PortfolioIndustrial Machinery Stocks with High ROCEBest Sectors To Invest in this Navratri
BSE SmallCap Select IndexSmall Cap Hotel StocksSanjay Gupta PortfolioTop Performed Focused Fund in 10 yearsBest Stocks to Invest in this Navratri
All Topics
Related Posts
Best Real Estate Penny Stocks English
Finance

Best Real Estate Penny Stocks

The table below shows the Best Real Estate Penny Stocks based on the Highest Market Capitalization. Name Market Cap (Cr) Close Price Unitech Ltd 2,367.75

Best PSU Bank Stocks English
Finance

Best PSU Bank Stocks – PSU Bank Stocks

The table below shows the best PSU bank stocks based on the highest market capitalisation and 1-year return. Stock Name Close Price ₹ Market Cap

Pharma Penny Stocks Under Rs 100 English
Finance

Pharma Penny Stocks Under Rs 100

The table below shows Pharma Penny Stocks Under Rs 100 based on the Highest Market Capitalization. Name Market Cap (₹ Cr) Close Price (₹) Morepen